What Is Diclofenac?

Diclofenac is a widely used nonsteroidal anti-inflammatory drug, or NSAID, taken to reduce pain, inflammation, and fever. It is used in tablets, capsules, topical gels, eye drops, injections, and veterinary formulations in some regions. Because it is designed to be biologically active at low doses and is consumed by large populations, diclofenac has become a high-priority pharmaceutical of environmental interest.

In drinking water science, diclofenac is treated as an emerging contaminant rather than a conventional regulated chemical. It is not usually present because of direct industrial spills into drinking water systems. Instead, it enters the aquatic environment through normal human use, excretion, disposal of unused medicines, hospital effluent, pharmaceutical manufacturing discharges, and wastewater treatment plant releases. Conventional wastewater treatment can reduce diclofenac, but removal is often incomplete and variable.

Diclofenac is important because it has been repeatedly measured in rivers and streams downstream of wastewater treatment plants, and in some studies it has been detected at trace levels in raw water used for drinking water production. Its environmental significance is well established for aquatic organisms, especially because chronic exposure can affect fish, invertebrates, and other wildlife at concentrations relevant to contaminated surface waters. For humans, concentrations in finished drinking water are typically far below therapeutic doses, but the compound remains a concern because exposure can be long-term, involuntary, and combined with many other pharmaceuticals and wastewater-derived chemicals.

Scientific Identity

Diclofenac is an organic pharmaceutical compound with the molecular formula C₁₄H₁₁Cl₂NO₂. Its structure includes two chlorine atoms, an anilino group, and an acetic acid side chain. In water, diclofenac behaves as a weak acid and is often present as a negatively charged anion at typical drinking water pH. This ionic behavior strongly influences how it moves through soils, how it interacts with activated carbon, and how efficiently it is removed by membrane and oxidation processes.

The parent compound is the main monitoring target, but diclofenac can also form transformation products during wastewater treatment, chlorination, photolysis, and advanced oxidation. These byproducts may include hydroxylated, chlorinated, or oxidized derivatives. Their toxicity and persistence can differ from the parent drug, which is one reason diclofenac is studied as part of a broader mixture of pharmaceutical residues rather than as a single isolated substance.

Diclofenac is moderately hydrophobic compared with many small pharmaceuticals, but its ionized form increases mobility in water. It can undergo sunlight-driven photodegradation in shallow, clear surface waters, yet it may persist in turbid waters, shaded streams, groundwater, wastewater effluent channels, and distribution-relevant source waters. Its behavior is therefore site-specific: strong sunlight, long residence time, and reactive treatment conditions can reduce it, while continuous wastewater input can maintain a persistent low-level presence.

How Diclofenac Enters Drinking Water

The main pathway is domestic wastewater. After people use diclofenac, a portion is excreted as the unchanged drug and as metabolites that can sometimes transform back or contribute to the same analytical signal depending on the method. These residues enter sewers and wastewater treatment plants. Standard biological treatment is not designed specifically for trace pharmaceuticals, so removal can range from substantial to poor depending on plant design, sludge age, microbial community, temperature, hydraulic retention time, and whether tertiary treatment is used.

Hospital wastewater can be a concentrated local source because diclofenac is used for post-surgical pain, musculoskeletal disorders, and inflammatory conditions. Pharmaceutical manufacturing facilities can also be important sources where discharge controls are inadequate. Although consumer use is usually more diffuse, it can dominate the total load in large urban watersheds because millions of individual doses flow into sewer systems over time.

Diclofenac can reach drinking water supplies when treated wastewater is discharged upstream of an intake, when rivers with wastewater influence are used for municipal supply, or when riverbank filtration draws surface water into aquifers. It may also enter shallow groundwater where septic systems, leaking sewer infrastructure, or reclaimed water irrigation influence recharge areas. Disposal of unused medication down sinks or toilets is an avoidable pathway that can increase wastewater loading.

Occurrence and Exposure

Diclofenac is most commonly reported in wastewater effluent and downstream surface waters at trace concentrations, often in the nanogram-per-liter to low microgram-per-liter range depending on the watershed and sampling conditions. It is less frequently detected in finished drinking water, but detections have been reported in studies of wastewater-impacted drinking water sources, especially where conventional treatment is the only barrier or where source water contains a strong treated effluent component.

Exposure through drinking water is generally much smaller than exposure from taking diclofenac as a medication. However, drinking water exposure is different in character: it can occur daily, affect people who did not choose to take the drug, and involve mixtures of many other pharmaceuticals such as ibuprofen, naproxen, carbamazepine, caffeine, and hormone-active compounds. These mixtures complicate risk assessment because low-dose combined exposure is harder to interpret than exposure to one drug at a known therapeutic dose.

People most likely to encounter diclofenac in tap water are those served by utilities using surface waters downstream of major wastewater discharges, communities using indirect potable reuse, and households relying on shallow wells in areas with septic influence or reclaimed water recharge. Seasonal variation can occur. Low river flow, high wastewater contribution, reduced sunlight, colder biological treatment conditions, and high community drug use can increase measured concentrations.

Health Effects and Risk

Diclofenac has well-known pharmacological effects when used as a medicine. At therapeutic doses, it can affect prostaglandin synthesis through cyclooxygenase inhibition. Known clinical concerns include gastrointestinal irritation and bleeding, kidney stress, liver enzyme changes, fluid retention, blood pressure effects, and cardiovascular risk in susceptible users. These effects are associated with medication-level exposure, not with the extremely small concentrations usually measured in finished drinking water.

The drinking water concern is not acute poisoning. Instead, diclofenac is classified as a medium-level emerging contaminant issue because scientific uncertainty remains around chronic trace exposure, sensitive populations, transformation products, and mixture effects. Infants, pregnant people, individuals with kidney or liver disease, and people already taking NSAIDs may be considered more relevant from a precautionary perspective, although current environmental concentrations in drinking water are typically many orders of magnitude below prescribed doses.

Diclofenac is also notable for its environmental toxicity. It has caused serious ecological concern in wildlife, and laboratory studies show effects in aquatic organisms including tissue damage, altered enzyme activity, and reproductive or developmental impacts under certain exposure conditions. While ecological toxicity does not directly translate into human drinking water risk, it demonstrates that diclofenac remains biologically active outside the body and supports the need for monitoring in wastewater-impacted watersheds.

Testing and Monitoring

Diclofenac requires specialized laboratory analysis. It is not detected by routine household test strips, standard mineral panels, chlorine tests, hardness tests, or basic bacteriological sampling. Laboratories typically use solid-phase extraction to concentrate large water samples, followed by liquid chromatography coupled with tandem mass spectrometry, commonly reported as LC-MS/MS. High-resolution mass spectrometry may be used when screening for diclofenac metabolites and transformation products.

Accurate testing is challenging because expected concentrations are very low. Sample containers, holding times, filtration, preservation, matrix effects, and laboratory reporting limits all matter. A meaningful laboratory report should provide a method detection limit or reporting limit low enough for environmental trace analysis, quality-control recoveries, and confirmation ions or transitions specific to diclofenac. For drinking water investigations, laboratories may analyze both raw source water and finished water to evaluate treatment removal.

Monitoring is most useful where there is a plausible pathway: downstream of wastewater treatment plants, in water reuse systems, in bank-filtered supplies, in wells near septic-dense areas, or in surface-water utilities with high wastewater influence. One-time sampling can miss seasonal peaks, so repeated sampling during low-flow conditions and different treatment seasons gives a more reliable picture.

Treatment Methods

Diclofenac treatment is technically possible, but effectiveness depends on water chemistry, contact time, membrane integrity, oxidant dose, and competing organic matter. The best approach is usually an advanced treatment train rather than a single basic filter. For municipal systems, this may include ozonation, biologically active carbon, granular activated carbon, reverse osmosis, or advanced oxidation. For homes, point-of-use systems are usually more practical than whole-house systems unless the issue involves a private well and a broad contaminant mixture.

Advanced treatment works best when it is designed for trace organic contaminants rather than for taste, odor, or sediment alone. Ozone and advanced oxidation can chemically transform diclofenac, while activated carbon and reverse osmosis physically remove it from the finished water stream. Failure can occur when carbon is not replaced, RO membranes are poorly maintained, oxidation is underdosed, or the source water has high organic matter that consumes oxidants and adsorption capacity.

For a household concerned about diclofenac in public tap water, a certified point-of-use reverse osmosis system or a high-quality activated carbon system designed for pharmaceutical reduction is usually more reasonable than whole-house treatment. Whole-house treatment may be considered for private wells influenced by wastewater or septic systems, but it should be based on laboratory results and should address the full contaminant profile, not diclofenac alone.

Regulations and Guidelines

Diclofenac is not regulated in many countries as a conventional drinking water contaminant with a universal enforceable limit. In the United States, the U.S. Environmental Protection Agency has not established a federal Maximum Contaminant Level specifically for diclofenac in drinking water. It is more often addressed through research monitoring, wastewater studies, source-water assessments, and emerging contaminant programs.

Internationally, regulatory status is evolving. Some jurisdictions have evaluated diclofenac under surface-water, wastewater, or pharmaceutical environmental risk frameworks, and it has been considered in European monitoring discussions because of its aquatic toxicity and frequent occurrence downstream of wastewater discharges. Drinking water guidance can differ by country, state, province, water agency, or health authority. Some agencies may use health-based screening values or precautionary benchmarks rather than legally enforceable drinking water limits.

Because diclofenac sits at the intersection of medicine use, wastewater management, environmental protection, and drinking water safety, regulation may develop unevenly. A water utility may monitor it voluntarily if source water is wastewater-impacted, while another utility in a protected watershed may not test for it at all. Consumers should interpret results in context, comparing concentrations with laboratory detection limits, local guidance, and the presence of related pharmaceutical indicators.

Related Contaminants

Frequently Asked Questions

Is diclofenac commonly found in drinking water?

Diclofenac is more commonly found in wastewater effluent and wastewater-impacted rivers than in finished drinking water. It can appear in tap water when a drinking water source receives substantial treated wastewater and treatment barriers are not optimized for trace pharmaceuticals.

Does boiling water remove diclofenac?

No. Boiling is not a reliable treatment for diclofenac because it is not a volatile contaminant that simply evaporates away. Boiling can reduce microbial risk, but it does not provide dependable removal of dissolved pharmaceutical residues and may concentrate them slightly as water volume decreases.

What home filter is best for diclofenac?

For drinking and cooking water, point-of-use reverse osmosis is generally one of the strongest household options. High-quality activated carbon can also reduce diclofenac, especially when cartridges are replaced on schedule. A system should be selected for trace organic or pharmaceutical reduction rather than only for chlorine taste and odor.

Is diclofenac in water dangerous to humans?

At the trace concentrations usually reported in treated drinking water, diclofenac exposure is far below medical doses. The concern is mainly long-term uncertainty, mixture exposure, sensitive populations, and the fact that diclofenac remains biologically active in the environment. It is a precautionary monitoring issue rather than a typical acute poisoning risk.

Why is diclofenac considered an emerging contaminant?

Diclofenac is considered emerging because monitoring technology now detects it at very low concentrations, its regulation is still developing, and conventional treatment was not designed around pharmaceutical residues. Its repeated occurrence downstream of wastewater treatment plants makes it a useful indicator of pharmaceutical contamination in source waters.